![Rita Balice-Gordon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 500 223 $ au 31/08/2026
Rita Balice-Gordon is currently an Independent Director at Collegium Pharmaceutical, Inc. since 2020, a Director at Capsida Biotherapeutics, Inc. since 2021, a Director at H.
Lundbeck A starting in 2026, and a Director at Muna Therapeutics ApS starting in 2026.
Former roles include Vice President-Neuroscience & Pain Research Unit at Pfizer Inc., Global Head-Rare & Neurological Diseases at Sanofi, Inc., and Professor at Perelman School of Medicine.
Education includes undergraduate studies at Northwestern University and a doctorate from The University of Texas at Austin.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/05/2026 | 20 326 ( 0,06 % ) | 500 223 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Directeur/Membre du Conseil | 24/09/2020 |
| H. LUNDBECK A/S | Directeur/Membre du Conseil | 18/03/2026 |
Muna Therapeutics ApS
 Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Directeur/Membre du Conseil | 01/07/2021 |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Directeur/Membre du Conseil | 12/05/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
Perelman School of Medicine
 Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Perelman School of Medicine
Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Muna Therapeutics ApS
Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
